Clinical trial
Efficacy and Safety of Diabetes-specific Formula in Patients With Type 2 Diabetes Mellitus
NCT04622722 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Diabetes-specific Formula in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 22, 2018
- Completion date
- May 16, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.